JT, K. (2020). Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches. CNS drugs, 34(9), 947. https://doi.org/10.1007/s40263-020-00752-2
Chicago Style (17th ed.) CitationJT, Kantrowitz. "Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches." CNS Drugs 34, no. 9 (2020): 947. https://doi.org/10.1007/s40263-020-00752-2.
MLA (9th ed.) CitationJT, Kantrowitz. "Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches." CNS Drugs, vol. 34, no. 9, 2020, p. 947, https://doi.org/10.1007/s40263-020-00752-2.
Warning: These citations may not always be 100% accurate.